This Article Full Text (PDF) All Versions of this Article: 0897190008318131v1 21/5/356    most recent References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Eiland, L. S. Search for Related Content Social Bookmarking                         What's this?

Increasing Prevalence of Pneumococcal Serotype 19A Among US Children

Auburn University Harrison School of Pharmacy, Alabama, eilanls{at}auburn.edu

The incidence of invasive pneumococcal disease in children has drastically decreased since the introduction of the 7-valent pneumococcal conjugate vaccine in the United States in 2000. However, epidemiology studies are now finding that non-vaccine serotypes are emerging and are associated with multidrug resistance. Specifically, the incidence of the non-vaccine serotype 19A causing invasive pneumococcal disease has increased over the past few years. Several studies from various areas of the United States report changes in serotypes and antimicrobial resistance associated with Streptococcus pneumoniae causing invasive disease, such as meningitis, bacteremia, and pneumonia. Evidence regarding the 19A isolate emergence in otitis media and mastoiditis is now being identified and detailed. Practitioners must be aware of this evolving pneumococcal organism and the potential clinical impact in children.

Key Words: multidrug resistance • streptococcus pneumoniae • child • pneumonia • bacteremia

This version was published on October 1, 2008

Journal of Pharmacy Practice, Vol. 21, No. 5, 356-362 (2008)
DOI: 10.1177/0897190008318131


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?